PAQR3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.74915637529693E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.7390537594747E-14 |
Normal-vs-Stage2 |
1.28040000046958E-07 |
Normal-vs-Stage3 |
5.97299987248334E-14 |
Normal-vs-Stage4 |
3.28814753203233E-12 |
Stage1-vs-Stage2 |
1.721980E-01 |
Stage1-vs-Stage3 |
8.655600E-01 |
Stage1-vs-Stage4 |
7.101200E-01 |
Stage2-vs-Stage3 |
1.989040E-01 |
Stage2-vs-Stage4 |
3.188000E-01 |
Stage3-vs-Stage4 |
6.831000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.86739512741951E-12 |
Normal-vs-AfricanAmerican |
1.62769797640294E-12 |
Normal-vs-Asian |
3.75380000000591E-05 |
Caucasian-vs-AfricanAmerican |
2.495900E-02 |
Caucasian-vs-Asian |
7.629800E-01 |
AfricanAmerican-vs-Asian |
1.618000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.11417558407356E-13 |
Normal-vs-Female |
5.25135490647699E-14 |
Male-vs-Female |
4.347600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.1094237467878E-14 |
Normal-vs-Age(41-60Yrs) |
1.73361325295218E-12 |
Normal-vs-Age(61-80Yrs) |
8.888445535149E-13 |
Normal-vs-Age(81-100Yrs) |
4.29822843983629E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.001640E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.234100E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.918000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.456000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.041600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.050800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.30479960169794E-10 |
Normal-vs-Grade 2 |
2.13618012168126E-12 |
Normal-vs-Grade 3 |
1.66622271535743E-12 |
Normal-vs-Grade 4 |
1.10467190950203E-12 |
Grade 1-vs-Grade 2 |
2.190400E-01 |
Grade 1-vs-Grade 3 |
5.116800E-01 |
Grade 1-vs-Grade 4 |
4.173600E-01 |
Grade 2-vs-Grade 3 |
4.370000E-01 |
Grade 2-vs-Grade 4 |
6.884400E-01 |
Grade 3-vs-Grade 4 |
9.121200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.89608353859694E-14 |
Normal-vs-ccB subtype |
2.75209854905256E-11 |
ccA subtype-vs-ccB subtype |
1.930490E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.53614923401346E-12 |
Normal-vs-N1 |
2.343600E-03 |
N0-vs-N1 |
4.684000E-01 |
|
|